| scholarly article | Q13442814 |
| P50 | author | Janja Pretnar-Oblak | Q61010044 |
| P2093 | author name string | Senta Frol | |
| P2860 | cites work | Influence of antidepressants on hemostasis | Q24635625 |
| Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation | Q28165271 | ||
| Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas | Q28176992 | ||
| Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage | Q28192577 | ||
| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation | Q29614696 | ||
| Apixaban versus warfarin in patients with atrial fibrillation | Q29617563 | ||
| Outcome of intracerebral hemorrhage associated with different oral anticoagulants | Q33617298 | ||
| Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation | Q34141211 | ||
| Statin use following intracerebral hemorrhage: a decision analysis | Q35170660 | ||
| Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants | Q35867449 | ||
| Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC Registry | Q36266774 | ||
| Death and disability from warfarin-associated intracranial and extracranial hemorrhages | Q36501858 | ||
| Prognostic factors in patients with intracerebral haematoma | Q36966012 | ||
| Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis | Q37670468 | ||
| Intracerebral bleeding in patients on antithrombotic agents | Q38151484 | ||
| Intracranial hemorrhage and novel anticoagulants for atrial fibrillation: what have we learned? | Q38197124 | ||
| Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. | Q40458214 | ||
| Can we rely on RE-LY? | Q43283546 | ||
| Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study | Q43787550 | ||
| Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials | Q43978668 | ||
| Oral-anticoagulant-related intracerebral hemorrhage | Q44314658 | ||
| The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage | Q44865336 | ||
| Platelet activity and outcome after intracerebral hemorrhage | Q46067834 | ||
| Statins, low cholesterol, and hemorrhagic stroke: an uncertain triangle | Q46549269 | ||
| Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. | Q51368043 | ||
| Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | Q56620375 | ||
| Intracranial hemorrhage and oral anticoagulant treatment | Q73765182 | ||
| Hematoma growth in oral anticoagulant related intracerebral hemorrhage | Q81785203 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | vitamin K | Q182338 |
| P304 | page(s) | 19-25 | |
| P577 | publication date | 2017-10-11 | |
| P1433 | published in | Interventional neurology | Q26842342 |
| P1476 | title | Early Outcome after Intracranial Hemorrhage Related to Non-Vitamin K Oral Anticoagulants | |
| P478 | volume | 7 |
Search more.